Epizyme
EPZM
$1.47
Share price
0.00%
Change (1 day)
-65.57%
Change (1 year)
Categories
Epizyme (EPZM) Fails to deliver data
Key failure to deliver metrics for Epizyme:
- Last SEC data release: 2023-07-14
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: $2.42 M
Failures to deliver for Epizyme (EPZM) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Epizyme (EPZM) - since 2013
Volume in USD (price x number of shares), data since 2013Epizyme (EPZM) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2022 | $6.71 M | 16.52% |
| 2021 | $5.76 M | -50.75% |
| 2020 | $11.69 M | 50.14% |
| 2019 | $7.79 M | 56.82% |
| 2018 | $4.96 M | -56.79% |
| 2017 | $11.49 M | 60.55% |
| 2016 | $7.16 M | -68.12% |
| 2015 | $22.46 M | -59.32% |
| 2014 | $55.22 M | 170.03% |
| 2013 | $20.45 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Novartis NVS | $30.53 M | $95.22 M | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $62.08 M | $0.14 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.53 M | $26.02 M | 🇬🇧 UK |
 Seagen
SGEN | N/A | $38.78 M | 🇺🇸 USA |